<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30389842</article-id>
<article-id pub-id-type="pmc">6331651</article-id>
<article-id pub-id-type="publisher-id">2040-18</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.2040-18.2018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Cellular/Molecular</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>An Alternative Exon of CAPS2 Influences Catecholamine Loading into LDCVs of Chromaffin Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ratai</surname>
<given-names>Olga</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schirra</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rajabov</surname>
<given-names>Elvin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brunk</surname>
<given-names>Irene</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ahnert-Hilger</surname>
<given-names>Gudrun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chitirala</surname>
<given-names>Praneeth</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Becherer</surname>
<given-names>Ute</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stevens</surname>
<given-names>David R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-6160-3954</contrib-id>
<name>
<surname>Rettig</surname>
<given-names>Jens</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine, Saarland University, 66421 Homburg, Germany, and </aff>
<aff id="aff2"><sup>2</sup>Department of Integrative Anatomy, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Jens Rettig,
<addr-line>Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Building 48, 66421 Homburg, Germany.</addr-line><email>jrettig@uks.eu</email></corresp>
<fn fn-type="con">
<p>Author contributions: G.A.-H. and J.R. edited the paper; D.R.S. wrote the first draft of the paper. G.A.-H., D.R.S., and J.R. designed research; O.R., C.S., E.R., I.B., P.C., and U.B. performed research; O.R. and C.S. analyzed data.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>2</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>7</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>39</volume>
<issue>1</issue>
<fpage>18</fpage>
<lpage>27</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>1</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 the authors 0270-6474/19/390018-10$15.00/0</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns00119000018.pdf"></self-uri>
<abstract>
<p>The calcium-dependent activator proteins for secretion (CAPS) are priming factors for synaptic and large dense-core vesicles (LDCVs), promoting their entry into and stabilizing the release-ready state. A modulatory role of CAPS in catecholamine loading of vesicles has been suggested. Although an influence of CAPS on monoamine transporter function and on vesicle acidification has been reported, a role of CAPS in vesicle loading is disputed. Using expression of naturally occurring splice variants of CAPS2 into chromaffin cells from CAPS1/CAPS2 double-deficient mice of both sexes, we show that an alternative exon of 40 aa is responsible for enhanced catecholamine loading of LDCVs in mouse chromaffin cells. The presence of this exon leads to increased activity of both vesicular monoamine transporters. Deletion of CAPS does not alter acidification of vesicles. Our results establish a splice-variant-dependent modulatory effect of CAPS on catecholamine content in LDCVs.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> The calcium activator protein for secretion (CAPS) promotes and stabilizes the entry of catecholamine-containing vesicles of the adrenal gland into a release-ready state. Expression of an alternatively spliced exon in CAPS leads to enhanced catecholamine content in chromaffin granules. This exon codes for 40 aa with a high proline content, consistent with an unstructured loop present in the portion of the molecule generally thought to be involved in vesicle priming. CAPS variants containing this exon promote serotonin uptake into Chinese hamster ovary cells expressing either vesicular monoamine transporter. Epigenetic tuning of CAPS variants may allow modulation of endocrine adrenaline and noradrenaline release. This mechanism may extend to monoamine release in central neurons or in the enteric nervous system.</p>
</abstract>
<kwd-group>
<kwd>amperometry</kwd>
<kwd>chromaffin cells</kwd>
<kwd>exocytosis</kwd>
<kwd>large dense-core vesicles</kwd>
<kwd>priming</kwd>
<kwd>readily releasable pool</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>